期刊文献+

脊索瘤的基础与临床研究进展 被引量:2

Advance in basic and clinical research on the treatment of choradoma
下载PDF
导出
摘要 脊索瘤是一种较为罕见的起源于胚胎时期残余脊索组织的恶性原发性骨肿瘤,呈低至中度恶性。脊索瘤以局部侵袭性及高复发性为特点,治疗上以手术为主,其对传统的放化疗均不敏感且患者术后复发率较高,预后较差。文中对脊索瘤治疗的基础与临床研究进展作一综述。 Chordoma is a rare low and moderate-grade malignant tumor originated in the embryonic period residual notochord tissue. Due to its critical location,local aggressive nature,and high recurrence,chordoma is not sensitive to radiotherapy and chemotherapy with poor prognosis. Surgery is the main treatment method. Here we present a review focusing on basic and clinical research progress of chordoma.
出处 《医学研究生学报》 CAS 北大核心 2015年第2期203-206,共4页 Journal of Medical Postgraduates
基金 国家自然科学基金(81102039)
关键词 骶尾部 脊索瘤 治疗 重建 Sacrococcygeal region Chordoma Treatment Reconstruction
  • 相关文献

参考文献36

  • 1McMaster ML, Goldstein AM, Bromley CM, et al. Chordoma: incidence and survival patterns in the United States, 1973-1995 [J]. Cancer Causes Control, 2001, 12(1) : 1-11.
  • 2樊根涛,孙国静,黎承军,周光新,蔡滕,施鑫,吴苏稼.副脊索瘤的临床分析[J].医学研究生学报,2014,27(4):447-448. 被引量:5
  • 3Diaz RJ, Cusimano MD. The biological basis for modern treat- ment of chordoma[ J]. Meuro Oncol, 2011, 104(2) : 411422.
  • 4Bozzi F, Manenti G, Conca E, et al. Development of transplant- able human chordoma xenograft for preclinical assessment of no-vel therapeutic strategies[J]. Neuro Oncol, 2014, 16 ( 1 ) : 72- 80.
  • 5Mukherjee D, Chaichana KL, Gokaslan ZL, et al. Survival of patients with malignant primary osseous spinal neoplasms :results from the surveillance , epidemiology , and results (SEER) data- base from 1973 to 2003[J]. J Neurosurg Spine, 2011, 14(2) : 143-150.
  • 6Rahmah NN, Sakai K, Nakayama J, et al. Reversion-inducing cysteine-rich protein with kazal motifs and matrix metalloprotein- ase-9 are prognostic markers in skull base chordomas[ J]. Neuro- surg Rev, 2010, 33(2) : 167-173.
  • 7Froehlich EV, Scheipl S, Laz0xy A, et al. Expression of ezrin, MMP-9, and COX-2 in 50 chordoma specimens: a clinical and immunohistochemical analysis [ J ]. Spine ( Phila Pa 1976 ) , 2012, 37(13) : E757-E767.
  • 8Schwab H, Boland PJ, Agaram NP, et al. Chordoma and chon- drosarcoma gene profile : implications for immunotherapy [ J ]. Cancer Immunol Immunother, 2009, 58 (3) : 339-349.
  • 9Vujovic S, Henderson S, presmeau N, et al. Brachyury, acru- cial regulator of notochordal development, is a novel biomarker for chordomas[J] J Pathol, 2006, 209(2) : 157-165.
  • 10Shen J, Li CD, Yang HL, et al. Classic claordoma coxisting with benign notochordal cell rest demonstrating different immunohisto- logical expression patterns of brachyury and galectin-3 [ J ] . J Clin Neurosci, 2011, 18( 1 ) : 96-99.

二级参考文献91

共引文献42

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部